|
| 36441429 | Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome. | J Autism Dev Disord | 2024 |
| 37881024 | CDKL5 deficiency disorder: At the intersection between Rett syndrome and developmental epileptic encephalopathies. | Dev Med Child Neurol | 2024 |
| 37198960 | Sleep disturbances in Phelan-McDermid syndrome: Clinical and metabolic profiling of 56 individuals. | Clin Genet | 2023 |
| 37515316 | Concentration-QTc Relationship from a Single Ascending Dose Study of ANAVEX3-71, a Novel Sigma-1 Receptor and Allosteric M1 Muscarinic Receptor Agonist in Development for the Treatment of Frontotemporal Dementia, Schizophrenia, and Alzheimer's Disease. | Clin Pharmacol Drug Dev | 2023 |
| 37840096 | Sensory Symptoms and Signs of Hyperarousal in Individuals with Fragile X Syndrome: Findings from the FORWARD Registry and Database Multisite Study. | J Autism Dev Disord | 2023 |
| 37651202 | Effects of AFQ056 on language learning in fragile X syndrome. | J Clin Invest | 2023 |
| 37104862 | Rett Syndrome Behaviour Questionnaire in Children and Adults With Rett Syndrome: Psychometric Characterization and Revised Factor Structure. | Am J Intellect Dev Disabil | 2023 |
| 34664257 | Genetic and metabolic profiling of individuals with Phelan-McDermid syndrome presenting with seizures. | Clin Genet | 2022 |
| 35568815 | Anxiety-like behavior and anxiolytic treatment in the Rett syndrome natural history study. | J Neurodev Disord | 2022 |
| 35852003 | Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. | Mol Genet Genomic Med | 2022 |
| 35661397 | Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma-1 receptor agonist Blarcamesine. | Am J Med Genet A | 2022 |
| 35712450 | Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome. | Front Neurosci | 2022 |
| 34889523 | Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort. | Am J Med Genet A | 2022 |
| 35148024 | The association between mosaicism type and cognitive and behavioral functioning among males with fragile X syndrome. | Am J Med Genet A | 2022 |
| 34028805 | Cerebral visual impairment in CDKL5 deficiency disorder: vision as an outcome measure. | Dev Med Child Neurol | 2021 |
| 34433831 | Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy. | Sci Rep | 2021 |
| 34818076 | Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. | J Child Adolesc Psychopharmacol | 2021 |
| 34388423 | Evaluating Sleep Disturbances in Children With Rare Genetic Neurodevelopmental Syndromes. | Pediatr Neurol | 2021 |
| 31342442 | Improving the Diagnosis of Autism Spectrum Disorder in Fragile X Syndrome by Adapting the Social Communication Questionnaire and the Social Responsiveness Scale-2. | J Autism Dev Disord | 2020 |
| 31985047 | Long QT interval in Rett syndrome: expanding the knowledge of a poorly understood phenomenon. | Dev Med Child Neurol | 2020 |
| 33211820 | A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials. | Am J Intellect Dev Disabil | 2020 |
| 33008014 | A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments. | Brain Sci | 2020 |
| 32636765 | Autism Spectrum Disorder Versus Autism Spectrum Disorders: Terminology, Concepts, and Clinical Practice. | Front Psychiatry | 2020 |
| 32932789 | Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. | Brain Sci | 2020 |
| 32756423 | Functional Network Mapping Reveals State-Dependent Response to IGF1 Treatment in Rett Syndrome. | Brain Sci | 2020 |
| 32951657 | Assessment of a Clinical Trial Metric for Rett Syndrome: Critical Analysis of the Rett Syndrome Behaviour Questionnaire. | Pediatr Neurol | 2020 |
| 32318621 | A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2-73) Phase 2a clinical study. | Alzheimers Dement (N Y) | 2020 |
| 32161522 | Metabolic Signatures Differentiate Rett Syndrome From Unaffected Siblings. | Front Integr Neurosci | 2020 |
| 30536762 | The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2. | Am J Med Genet B Neuropsychiatr Genet | 2019 |
| 31704481 | ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. | Pharmacol Biochem Behav | 2019 |
| 30217666 | Behavioral profiles in Rett syndrome: Data from the natural history study. | Brain Dev | 2019 |
| 31468273 | Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis. | J Autism Dev Disord | 2019 |
| 31229631 | Transcriptomic Studies in Mouse Models of Rett Syndrome: A Review. | Neuroscience | 2019 |
| 30918097 | Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome. | Neurology | 2019 |
| 31147226 | Severity Assessment in CDKL5 Deficiency Disorder. | Pediatr Neurol | 2019 |
| 31053667 | Hand stereotypies: Lessons from the Rett Syndrome Natural History Study. | Neurology | 2019 |
| 30788845 | Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndrome. | Clin Genet | 2019 |
| 30649225 | Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder. | Brain | 2019 |
| 29657083 | The course of awake breathing disturbances across the lifespan in Rett syndrome. | Brain Dev | 2018 |
| 30558274 | Best Practices in Fragile X Syndrome Treatment Development. | Brain Sci | 2018 |
| 29358616 | Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome. | Eur J Hum Genet | 2018 |
| 27171548 | Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2. | Genet Med | 2017 |
| 29875616 | Parents' initial concerns about the development of their children later diagnosed with fragile X syndrome. | J Intellect Dev Disabil | 2017 |
| 28390033 | A Novel Way to Measure and Predict Development: A Heuristic Approach to Facilitate the Early Detection of Neurodevelopmental Disorders. | Curr Neurol Neurosci Rep | 2017 |
| 28132121 | Assessment of Caregiver Inventory for Rett Syndrome. | J Autism Dev Disord | 2017 |
| 28347601 | Scoliosis in Rett Syndrome: Progression, Comorbidities, and Predictors. | Pediatr Neurol | 2017 |
| 29059905 | Classification of respiratory disturbances in Rett Syndrome patients using Restricted Boltzmann Machine. | Annu Int Conf IEEE Eng Med Biol Soc | 2017 |
| 29194024 | Adapting the Mullen Scales of Early Learning for a Standardized Measure of Development in Children With Rett Syndrome. | Intellect Dev Disabil | 2017 |
| 28814540 | Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. | Pediatrics | 2017 |
| 28814539 | FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome. | Pediatrics | 2017 |